Dermata Therapeutics, Inc. (NASDAQ:DRMAW – Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 11,000 shares, an increase of 15.8% from the March 31st total of 9,500 shares. Based on an average daily trading volume, of 5,100 shares, the short-interest […]
Dermata Therapeutics, Inc. (NASDAQ:DRMAW – Get Free Report) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 12,600 shares, a growth of 20.0% from the February 29th total of 10,500 shares. Based on an average daily volume of 5,700 shares, the days-to-cover ratio […]
Dermata Therapeutics, Inc. (NASDAQ:DRMAW – Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 12,600 shares, an increase of 20.0% from the February 29th total of 10,500 shares. Based on an average trading volume of 5,700 shares, […]
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) was the target of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 279,400 shares, a decline of 5.5% from the January 15th total of 295,600 shares. Based on an average trading volume of 947,300 shares, […]
Dermata Therapeutics, Inc. (NASDAQ:DRMA – Get Free Report) rose 5% during mid-day trading on Thursday . The stock traded as high as $0.49 and last traded at $0.47. Approximately 111,549 shares changed hands during mid-day trading, a decline of 93% from the average daily volume of 1,531,422 shares. The stock had previously closed at $0.44. […]